Searched for
PFIZER STOCK DROP
Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended largely unchanged as West Asia tensions tempered risk appetite. Broader markets outperformed despite recent correctio...- Why US stock market Dow Jones, S&P 500 and Nasdaq are surging big today: Dow jumps 350 points, Nasdaq jumps 250 points as Intel hits all-time high driving the rallyUS stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...
- US stock market today: Why is Nasdaq crashing big today? Dow and S&P 500 slip as Nasdaq plunges over 300 points - Nvidia, AMD, Intel lead tech lossesUS stock market today: Nasdaq crashing big today as Dow Jones and S&P 500 also slip. The US stock market today shows a sharp shift. The Nas...
- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
- US stock market today: Dow, S&P 500, Nasdaq Pull Back from record highs as Gold hits fresh all-time peakUS stocks fell slightly as investors waited for Fed speeches and key inflation data. Gold hit a record high while Bitcoin and other cryptoc...
- Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan PharmaceuticalsPfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacita...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Pfizer and Moderna stocks drop after RFK Jr.'s nomination for Health Secretary: impact on the Pharma IndustryShares of leading vaccine producers, such as Pfizer and Moderna, experienced notable drops after Robert F. Kennedy Jr. was announced as Pre...
- Pfizer shares sink after it resets 2024 Covid expectationsRevenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a fur...
- Esab India, Muthoot Finance among 5 stocks with bearish RSIOn August 3, Thursday, StockEdge reported 11 stocks that were trading in the overbought zone but exhibited bearish or declining RSI trends....
- Vaccine-tied stocks flail after UK clears Pfizer-BioNTech shotPfizer’s next closest competitor working on a similar shot, Moderna Inc., sank 10% before eventually trading higher after Merck & Co. revea...
- 5 MNC stocks stand out as oasis in a desert amid market turmoilSelect names from the pack may even outperform the broader market in the short term.
- Pick-up in local market boosts pharma MNCsA pick-up in the local pharma market augurs well for MNCs which are still recovering from the adverse impact of drug price control on high-...
- Top three pharma MNCs Novartis, Pfizer and Abbott lose 10% in 2013Most MNCs have been facing heat due to fast expiring patents, challenges in new drug discovery and depleting product pipeline.
- Claris Lifesciences net profit falls 14%, USFDA clearance awaitingThe consolidated net profit stood at Rs 32.32 crore for second quarter ended on 30 June 2012 compared to Rs 37.72 crore for the same period...
- Biocon hits 52-week low as Pfizer scraps dealBiocon dropped more than 7% early to touch their 52-week low of Rs 238 after Pfizer terminated an agreement to sell insulin products.
- Pfizer: No immediate cure seen for short-term hiccupsPfizer India, the Indian arm of the US drug major Pfizer Inc, reported muted performance for the four months ended March 2011.
- Pfizer 4Q profit beats views as revenue up 6 pcPfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...
- Ranbaxy shares rise on buzz of Pfizer 'counter-offer'The share price of Ranbaxy Laboratories rose to a 3-year high on Friday based on the rumour that the world’s largest drug maker, Pfizer, ma...
- Pfizer CEO forced to retire in July to get $180m packagePfizer’s former chief executive, Henry A McKinnell, who was forced into an early retirement in part because of investor anger about his ric...
Load More
